Novo Nordisk has teamed up with HITLAB (Health Innovation Technology Lab, Inc.) to launch the 2017 HITLAB World Cup of Voice-Activated Technology in Diabetes presented by Novo Nordisk awarding prizes totaling $75,000. Managing diabetes requires strict adherence to dietary, physical activity, and medication protocols. For people living with diabetes, voice-activated technologies are an important way they can manage their disease.
Innovators should focus on enhancing patient outcomes, lowering healthcare costs without compromising quality, making the management of patients more efficient, or improving health and quality of life. Winning entries should demonstrate an ability to effectively address the unmet needs of the type 2 diabetes community. Projects must show how the voice-activated technology solution differs from current practice, technology, or services available to consumers, and they must provide a sound, sustainable business model.
“To successfully manage diabetes, people living with it need to be mindful of and track myriad things throughout their day, from blood sugar levels to counting calories,” said Amy West, Senior Director, Patient Centric Marketing & Digital Health, Novo Nordisk in a statement. “We at Novo Nordisk are constantly striving to provide solutions that minimize the burden for people living with diabetes, and believe that digital health, and specifically voice-activated technologies can be important tools for managing diabetes.”
The submission period is currently open and will close on Wednesday, October 11. Finalists will be announced on October 23. They will make pitches at the HITLAB Innovators Summit, which will be held in New York City. Pitches are judged by an impartial panel of healthcare experts assigned by Novo Nordisk and HITLAB.
For official rules and registration information, click here.
